2024 Q3 Form 10-Q Financial Statement
#000107997324001177 Filed on August 08, 2024
Income Statement
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| Revenue | $3.073M | $3.119M |
| YoY Change | 18.46% | 35.13% |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $1.320M | |
| YoY Change | 37.27% | |
| % of Gross Profit | ||
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $9.330K | |
| YoY Change | 49.04% | |
| % of Gross Profit | ||
| Operating Expenses | $1.568M | |
| YoY Change | 35.93% | |
| Operating Profit | ||
| YoY Change | ||
| Interest Expense | $1.154M | $1.116M |
| YoY Change | 12.33% | 23.15% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $31.33K | $50.81K |
| YoY Change | 30.99% | 42.8% |
| Pretax Income | $406.8K | $435.2K |
| YoY Change | 163.33% | 75.02% |
| Income Tax | $106.2K | -$107.8K |
| % Of Pretax Income | 26.1% | -24.77% |
| Net Earnings | $300.6K | $327.5K |
| YoY Change | 157.1% | 86.01% |
| Net Earnings / Revenue | 9.78% | 10.5% |
| Basic Earnings Per Share | $0.09 | $0.11 |
| Diluted Earnings Per Share | $0.07 | $0.09 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 2.905M shares | 2.905M shares |
| Diluted Shares Outstanding | 4.179M shares | 3.664M shares |
Balance Sheet
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.040K | |
| YoY Change | -99.3% | |
| Cash & Equivalents | $2.150K | $1.044K |
| Short-Term Investments | ||
| Other Short-Term Assets | $769.4K | |
| YoY Change | 95.41% | |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $68.17M | $71.05M |
| YoY Change | 13.58% | 26.16% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $132.0K | $132.5K |
| YoY Change | 41.02% | 34.59% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $488.5K | |
| YoY Change | -47.78% | |
| Total Long-Term Assets | $915.8K | $911.9K |
| YoY Change | -26.81% | -25.17% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $68.17M | $71.05M |
| Total Long-Term Assets | $915.8K | $911.9K |
| Total Assets | $69.08M | $71.96M |
| YoY Change | 12.75% | 25.07% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | ||
| YoY Change | ||
| Accrued Expenses | $1.809M | |
| YoY Change | 14.3% | |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $51.79M | |
| YoY Change | 26.64% | |
| Long-Term Debt Due | $2.790M | |
| YoY Change | 22.44% | |
| Total Short-Term Liabilities | $53.08M | $56.39M |
| YoY Change | 8.45% | 25.99% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $8.608M | |
| YoY Change | 30.81% | |
| Other Long-Term Liabilities | $139.2K | |
| YoY Change | 184.82% | |
| Total Long-Term Liabilities | $8.823M | $8.747M |
| YoY Change | 45.26% | 31.95% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $53.08M | $56.39M |
| Total Long-Term Liabilities | $8.823M | $8.747M |
| Total Liabilities | $61.91M | $65.14M |
| YoY Change | 12.51% | 26.76% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $3.671M | $3.399M |
| YoY Change | 29.23% | 23.49% |
| Common Stock | $3.001K | $2.905K |
| YoY Change | 3.3% | 0.0% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $7.177M | $6.828M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $69.08M | $71.96M |
| YoY Change | 12.75% | 25.07% |
Cashflow Statement
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $300.6K | $327.5K |
| YoY Change | 157.1% | 86.01% |
| Depreciation, Depletion And Amortization | $9.330K | |
| YoY Change | 49.04% | |
| Cash From Operating Activities | $3.468M | |
| YoY Change | 293.24% | |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $600.00 | |
| YoY Change | -91.84% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$4.719M | |
| YoY Change | 20.29% | |
| Cash From Investing Activities | -$4.720M | |
| YoY Change | 20.08% | |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 1.252M | |
| YoY Change | -57.36% | |
| NET CHANGE | ||
| Cash From Operating Activities | 3.468M | |
| Cash From Investing Activities | -4.720M | |
| Cash From Financing Activities | 1.252M | |
| Net Change In Cash | -100.0 | |
| YoY Change | -99.91% | |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $3.468M | |
| Capital Expenditures | $600.00 | |
| Free Cash Flow | $3.467M | |
| YoY Change | 296.48% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2024Q2 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
usd | |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6396844 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
7050 | usd |
| CY2024Q1 | spfx |
Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
|
-29050 | usd |
| CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
118802 | usd |
| CY2024Q2 | us-gaap |
Profit Loss
ProfitLoss
|
327452 | usd |
| CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6828148 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
446254 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
244921 | usd | |
| us-gaap |
Depreciation
Depreciation
|
17297 | usd | |
| us-gaap |
Depreciation
Depreciation
|
12515 | usd | |
| us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
57251 | usd | |
| us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
56942 | usd | |
| us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
6628 | usd | |
| us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
6628 | usd | |
| us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
529179 | usd | |
| us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
346781 | usd | |
| us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
-788 | usd | |
| us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
-57038 | usd | |
| spfx |
Options Issued For Services
OptionsIssuedForServices
|
14100 | usd | |
| spfx |
Options Issued For Services
OptionsIssuedForServices
|
14100 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
462143 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
44929 | usd | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
76000 | usd | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
28836 | usd | |
| spfx |
Increasedecrease In Drafts Payable
IncreasedecreaseInDraftsPayable
|
4358894 | usd | |
| spfx |
Increasedecrease In Drafts Payable
IncreasedecreaseInDraftsPayable
|
1034062 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
134195 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
174346 | usd | |
| us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-57251 | usd | |
| us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-56942 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4969192 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1816626 | usd | |
| spfx |
Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
|
10070593 | usd | |
| spfx |
Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
|
6650852 | usd | |
| us-gaap |
Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
|
13157 | usd | |
| us-gaap |
Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
|
14546 | usd | |
| us-gaap |
Proceeds From Sale Of Insurance Investments
ProceedsFromSaleOfInsuranceInvestments
|
641934 | usd | |
| us-gaap |
Proceeds From Sale Of Insurance Investments
ProceedsFromSaleOfInsuranceInvestments
|
0 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
27268 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7348 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9469084 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-6672746 | usd | |
| us-gaap |
Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
|
304930 | usd | |
| us-gaap |
Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
|
0 | usd | |
| us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
1899483 | usd | |
| us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
5262046 | usd | |
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1353689 | usd | |
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
91668 | usd | |
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
85000 | usd | |
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
671576 | usd | |
| us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1028000 | usd | |
| us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
30000 | usd | |
| spfx |
Repayment Of Notes Payable Stockholders And Related Parties
RepaymentOfNotesPayableStockholdersAndRelatedParties
|
-0 | usd | |
| spfx |
Repayment Of Notes Payable Stockholders And Related Parties
RepaymentOfNotesPayableStockholdersAndRelatedParties
|
27000 | usd | |
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
6497 | usd | |
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
6165 | usd | |
| us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
43000 | usd | |
| us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
0 | usd | |
| us-gaap |
Repayments Of Other Debt
RepaymentsOfOtherDebt
|
52858 | usd | |
| us-gaap |
Repayments Of Other Debt
RepaymentsOfOtherDebt
|
38164 | usd | |
| spfx |
Dividends Paid On Series Convertible Preferred Stock
DividendsPaidOnSeriesConvertiblePreferredStock
|
29050 | usd | |
| spfx |
Dividends Paid On Series Convertible Preferred Stock
DividendsPaidOnSeriesConvertiblePreferredStock
|
58100 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4455697 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4582709 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-44195 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-273411 | usd | |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
45239 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
421211 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1044 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
147800 | usd |
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
271389 | usd | |
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
36041 | usd | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
2106917 | usd | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
1652987 | usd | |
| spfx |
Operating Lease Assets Obtained In Exchange For Lease Liabilities
OperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
|
235335 | usd | |
| spfx |
Operating Lease Assets Obtained In Exchange For Lease Liabilities
OperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
|
0 | usd | |
| CY2024Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
| CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
| CY2024Q2 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
473473 | usd |
| CY2023Q4 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
168543 | usd |
| CY2024Q2 | spfx |
Premium Finance Contracts Gross
PremiumFinanceContractsGross
|
73810442 | usd |
| CY2023Q4 | spfx |
Premium Finance Contracts Gross
PremiumFinanceContractsGross
|
63602075 | usd |
| CY2024Q2 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
100768405 | usd |
| CY2023Q4 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
87618261 | usd |
| us-gaap |
Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
|
0.174 | pure | |
| us-gaap |
Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
|
0.167 | pure | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_849_eus-gaap--UseOfEstimates_zxrOUs8vcSmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zg4qktbFg95i">Use of Estimates</span></b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for credit losses, depreciable lives of property and equipment, and valuation of stock-based compensation.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | ||
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zno0OaKex5Ec" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zBa4QXWwHpfh">Concentration of Credit and Financial Instrument Risk</span></b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and loans receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at these financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zkpXqkc0PxIj" title="FDIC insured amount">250,000</span>. Uninsured balances are $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20240630_zSRL5IvcZXVh" title="Uninsured balances">2,906</span> and $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20231231_zE4Q9NahAzJ3" title="Uninsured balances">250,200</span> at June 30, 2024 and December 31, 2023, respectively. The Company mitigates this risk by maintaining its cash balances at high-quality financial institutions. The following table provides a reconciliation between uninsured balances and cash per the consolidated balance sheets:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_zOdO0S0ZfcK9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt"><span id="xdx_8B3_z1BuRD7lyaM8" style="display: none">Schedule of reconciliation between uninsured balances and cash per the consolidated balance sheets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20240630_zL2aH7h077Tg" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20231231_zAHgA5njh1ph" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>June 30, 2024 <br/>(unaudited)</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_400_eus-gaap--CashUninsuredAmount_iI_pp0p0_maCAOAzgSw_z7ETSBghY4Sd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify; padding-left: 5.4pt">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,906</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">250,200</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--InsuredBalances_iI_pp0p0_maCAOAzgSw_zXSZz6imYug2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--BalancesAtInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0_maCAOAzgSw_zXFw0yzDHrFc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Balances at institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,239</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--PlusCashOverdraft_iI_pp0p0_maCAOAzgSw_zvUkVPwJRXxg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Cash overdraft</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,473</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,543</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--OutstandingChecks_iI_pp0p0_maCAOAzgSw_zKAvkjJ4Xloi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(726,379</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(668,743</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--CashAndOverdraftAmount_iTI_pp0p0_mtCAOAzgSw_zRE94fDF6qUf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Cash per consolidated balance sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">45,239</td><td style="text-align: left"> </td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zSjyDzB84Idc" title="Concentration risk percentage">64</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zIopKJZcaCpf" title="Concentration risk percentage">61</span>% of the Company’s business activity is with customers located in Florida for 2024 and 2023, respectively. Approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zRoiJqJhPYud" title="Concentration risk percentage">9</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zQZUcBrxxLec" title="Concentration risk percentage">10</span>% of the Company’s business activity is with customers located in Georgia for 2024 and 2023, respectively. Approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z2yH6u12RvMa" title="Concentration risk percentage">8</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zw0tEynt5x22" title="Concentration risk percentage">12</span>% of the Company's business activity is with customers located in North Carolina for 2024 and 2023, respectively. Approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zIk72vq7cfwf" title="Concentration risk percentage">11</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zByOPv8HFpn9" title="Concentration risk percentage">9</span>% of the Company's business activity is with customers located in South Carolina for 2024 and 2023, respectively. There were no other significant regional, industrial or group concentrations during the three months ended June 30, 2024 and 2023.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | ||
| CY2024Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
| CY2024Q2 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
2906 | usd |
| CY2023Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
250200 | usd |
| CY2024Q2 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
2906 | usd |
| CY2023Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
250200 | usd |
| CY2024Q2 | spfx |
Insured Balances
InsuredBalances
|
250000 | usd |
| CY2023Q4 | spfx |
Insured Balances
InsuredBalances
|
250000 | usd |
| CY2024Q2 | spfx |
Balances At Institutions That Do Not Exceed Fdic Limit
BalancesAtInstitutionsThatDoNotExceedFdicLimit
|
1044 | usd |
| CY2023Q4 | spfx |
Balances At Institutions That Do Not Exceed Fdic Limit
BalancesAtInstitutionsThatDoNotExceedFdicLimit
|
45239 | usd |
| CY2024Q2 | spfx |
Plus Cash Overdraft
PlusCashOverdraft
|
473473 | usd |
| CY2023Q4 | spfx |
Plus Cash Overdraft
PlusCashOverdraft
|
168543 | usd |
| CY2024Q2 | spfx |
Outstanding Checks
OutstandingChecks
|
-726379 | usd |
| CY2023Q4 | spfx |
Outstanding Checks
OutstandingChecks
|
-668743 | usd |
| CY2024Q2 | spfx |
Cash And Overdraft Amount
CashAndOverdraftAmount
|
1044 | usd |
| CY2023Q4 | spfx |
Cash And Overdraft Amount
CashAndOverdraftAmount
|
45239 | usd |
| CY2024Q2 | spfx |
Cash Surrender Values Of Life Insurance
CashSurrenderValuesOfLifeInsurance
|
665880 | usd |
| CY2023Q4 | spfx |
Cash Surrender Values Of Life Insurance
CashSurrenderValuesOfLifeInsurance
|
650237 | usd |
| CY2024Q2 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.0664 | pure |
| CY2024Q2 | spfx |
Interest Expense Borrowing
InterestExpenseBorrowing
|
8168 | usd |
| spfx |
Interest Expense Borrowing
InterestExpenseBorrowing
|
8168 | usd | |
| CY2023Q2 | spfx |
Interest Expense Borrowing
InterestExpenseBorrowing
|
0 | usd |
| spfx |
Interest Expense Borrowing
InterestExpenseBorrowing
|
0 | usd | |
| CY2024Q2 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
| CY2023Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
| CY2024Q2 | spfx |
Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
|
67470771 | usd |
| CY2023Q4 | spfx |
Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
|
57769501 | usd |
| CY2024Q2 | spfx |
Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
|
6339671 | usd |
| CY2023Q4 | spfx |
Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
|
5832574 | usd |
| CY2024Q2 | spfx |
Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
|
73810442 | usd |
| CY2023Q4 | spfx |
Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
|
63602075 | usd |
| CY2024Q2 | spfx |
Amounts Due From Agents
AmountsDueFromAgents
|
907390 | usd |
| CY2023Q4 | spfx |
Amounts Due From Agents
AmountsDueFromAgents
|
804131 | usd |
| CY2024Q2 | spfx |
Unearned Interest
UnearnedInterest
|
2630780 | usd |
| CY2023Q4 | spfx |
Unearned Interest
UnearnedInterest
|
2164914 | usd |
| CY2024Q2 | spfx |
Insurance Premium Finance Contract Net
InsurancePremiumFinanceContractNet
|
72087052 | usd |
| CY2023Q4 | spfx |
Insurance Premium Finance Contract Net
InsurancePremiumFinanceContractNet
|
62241292 | usd |
| CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1805939 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1501593 | usd |
| CY2024Q2 | spfx |
Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
|
70281113 | usd |
| CY2023Q4 | spfx |
Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
|
60739699 | usd |
| CY2024Q2 | spfx |
Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
|
1640503 | usd |
| CY2023Q4 | spfx |
Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
|
1336157 | usd |
| CY2024Q2 | spfx |
Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
|
165436 | usd |
| CY2023Q4 | spfx |
Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
|
165436 | usd |
| CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1805939 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1501593 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1501593 | usd |
| CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1129498 | usd |
| spfx |
Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
|
932000 | usd | |
| CY2023 | spfx |
Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
|
1669000 | usd |
| us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
836528 | usd | |
| CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
1639416 | usd |
| us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
208874 | usd | |
| CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
342511 | usd |
| CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1805939 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1501593 | usd |
| CY2024Q2 | spfx |
Current Additions To Allowance
CurrentAdditionsToAllowance
|
508000 | usd |
| CY2023Q2 | spfx |
Current Additions To Allowance
CurrentAdditionsToAllowance
|
320000 | usd |
| CY2024Q2 | spfx |
Less Contrarevenues
LessContrarevenues
|
203934 | usd |
| CY2023Q2 | spfx |
Less Contrarevenues
LessContrarevenues
|
165072 | usd |
| CY2024Q2 | us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
304066 | usd |
| CY2023Q2 | us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
154928 | usd |
| spfx |
Current Additions To Allowance
CurrentAdditionsToAllowance
|
932000 | usd | |
| spfx |
Current Additions To Allowance
CurrentAdditionsToAllowance
|
719000 | usd | |
| spfx |
Less Contrarevenues
LessContrarevenues
|
402821 | usd | |
| spfx |
Less Contrarevenues
LessContrarevenues
|
372219 | usd | |
| us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
529179 | usd | |
| us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
346781 | usd | |
| CY2024Q2 | spfx |
Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
|
67470771 | usd |
| CY2024Q2 | spfx |
Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
|
6339671 | usd |
| CY2024Q2 | spfx |
Premium Finance Contracts Gross
PremiumFinanceContractsGross
|
73810442 | usd |
| CY2023Q4 | spfx |
Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
|
57769501 | usd |
| CY2023Q4 | spfx |
Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
|
5832574 | usd |
| CY2023Q4 | spfx |
Premium Finance Contracts Gross
PremiumFinanceContractsGross
|
63602075 | usd |
| CY2024Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
413585 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
386317 | usd |
| CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
281114 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
263817 | usd |
| CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
132471 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
122500 | usd |
| CY2024Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
9330 | usd |
| CY2023Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
6258 | usd |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
17297 | usd | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
12515 | usd | |
| CY2024Q2 | us-gaap |
Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
|
0.0525 | pure |
| CY2023Q4 | us-gaap |
Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
|
0.0525 | pure |
| CY2024Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y3M29D | |
| CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y11M19D | |
| CY2024Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
34655 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
31382 | usd |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
69310 | usd | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
61438 | usd | |
| CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
258924 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
80840 | usd |
| CY2024Q2 | spfx |
Server Lease
ServerLease
|
32036 | usd |
| CY2023Q4 | spfx |
Server Lease
ServerLease
|
38664 | usd |
| CY2024Q2 | spfx |
Total Lease Assets
TotalLeaseAssets
|
290960 | usd |
| CY2023Q4 | spfx |
Total Lease Assets
TotalLeaseAssets
|
119504 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
119731 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
50594 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
139193 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
30246 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
258924 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
80840 | usd |
| CY2024Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
13516 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
13166 | usd |
| CY2024Q2 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
20546 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
27393 | usd |
| CY2024Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
34062 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
40559 | usd |
| CY2024Q2 | srt |
Drafts Payable
DraftsPayable
|
7040253 | usd |
| CY2023Q4 | srt |
Drafts Payable
DraftsPayable
|
2681359 | usd |
| CY2024Q2 | us-gaap |
Other Notes Payable
OtherNotesPayable
|
77649 | usd |
| CY2023Q4 | us-gaap |
Other Notes Payable
OtherNotesPayable
|
123924 | usd |
| CY2024Q2 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
77649 | usd |
| CY2023Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
92785 | usd |
| CY2024Q2 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
0 | usd |
| CY2023Q4 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
31139 | usd |
| CY2024Q2 | spfx |
Notes Payable Others
NotesPayableOthers
|
8134246 | usd |
| CY2023Q4 | spfx |
Notes Payable Others
NotesPayableOthers
|
6865557 | usd |
| CY2024Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2396642 | usd |
| CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2181400 | usd |
| CY2024Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
5737604 | usd |
| CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
4684157 | usd |
| CY2024Q2 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
134000 | usd |
| CY2023Q2 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
120000 | usd |
| us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
260000 | usd | |
| us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
248000 | usd | |
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1353689 | usd | |
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
91668 | usd | |
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
85000 | usd | |
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
671576 | usd | |
| CY2024Q2 | spfx |
Notes Payable Related Parties
NotesPayableRelatedParties
|
3116000 | usd |
| CY2023Q4 | spfx |
Notes Payable Related Parties
NotesPayableRelatedParties
|
2088000 | usd |
| CY2024Q2 | spfx |
Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
|
266000 | usd |
| CY2023Q4 | spfx |
Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
|
310000 | usd |
| CY2024Q2 | spfx |
Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
|
2850000 | usd |
| CY2023Q4 | spfx |
Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
|
1778000 | usd |
| CY2024Q2 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
54000 | usd |
| CY2023Q2 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
40000 | usd |
| us-gaap |
Interest Expense Other
InterestExpenseOther
|
98000 | usd | |
| us-gaap |
Interest Expense Other
InterestExpenseOther
|
79000 | usd | |
| us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
1028000 | usd | |
| us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
30000 | usd | |
| spfx |
Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
|
0 | usd | |
| spfx |
Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
|
27000 | usd | |
| CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2024Q2 | us-gaap |
Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
|
10 | |
| CY2024Q2 | us-gaap |
Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
|
1718100 | usd |
| CY2024Q2 | us-gaap |
Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
|
10 | |
| CY2024Q2 | us-gaap |
Dividends
Dividends
|
0 | usd |
| CY2023Q2 | us-gaap |
Dividends
Dividends
|
29050 | usd |
| us-gaap |
Dividends
Dividends
|
29050 | usd | |
| us-gaap |
Dividends
Dividends
|
58100 | usd | |
| CY2024Q2 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
58100 | usd |
| CY2023Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
29050 | usd |
| CY2024Q1 | us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
0 | usd |
| us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
0 | usd | |
| CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2905016 | shares |
| CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2905016 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2905016 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2905016 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
207400 | shares |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y7M24D | ||
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.18 | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
207400 | shares |
| spfx |
Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y7M24D | ||
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
1.18 | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
207400 | shares |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.18 | |
| CY2023 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P6Y1M24D | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
705224 | usd |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
|
0 | shares | |
| spfx |
Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
|
0 | ||
| spfx |
Share Based Compensation Arrangement By Share Based Payment Award Options Issued In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedInPeriodTotalIntrinsicValue
|
0 | usd | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | usd | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
207400 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.18 | |
| us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P5Y7M24D | ||
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
409001 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
207400 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.18 | |
| us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P5Y7M24D | ||
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
409001 | usd |
| CY2024Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
7050 | usd |
| CY2023Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
7050 | usd |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
14100 | usd | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
14100 | usd | |
| CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1035000 | shares |
| CY2023Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
7.09 | |
| CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P1Y7M6D | |
| CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
355600 | usd |
| spfx |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
|
0 | shares | |
| spfx |
Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
|
0 | ||
| spfx |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Issued
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueIssued
|
0 | usd | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
0 | shares | |
| spfx |
Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | usd | |
| spfx |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised
|
0 | usd | |
| CY2024Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1035000 | shares |
| CY2024Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
7.09 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P1Y29D | ||
| CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
0 | usd |
| CY2024Q2 | spfx |
Warrants Exercisable
WarrantsExercisable
|
1035000 | shares |
| CY2024Q2 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
7.09 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P1Y29D | ||
| CY2024Q2 | spfx |
Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1
|
0 | usd |
| CY2024Q2 | spfx |
Stock Warrant Expense
StockWarrantExpense
|
0 | usd |
| spfx |
Stock Warrant Expense
StockWarrantExpense
|
0 | usd | |
| CY2023Q2 | spfx |
Stock Warrant Expense
StockWarrantExpense
|
0 | usd |
| spfx |
Stock Warrant Expense
StockWarrantExpense
|
0 | usd | |
| CY2024Q2 | us-gaap |
Notes And Loans Payable Current
NotesAndLoansPayableCurrent
|
3116000 | usd |
| CY2023Q4 | us-gaap |
Notes And Loans Payable Current
NotesAndLoansPayableCurrent
|
2088000 | usd |
| CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
